✦ LIBER ✦

1123-184 Predictors of outcome in pulmonary artery hypertension patients on epoprostenol or bosentan therapy

✍ Scribed by Ajoy Kapoor; Richard Sheppard; Jessica Panyon; Michele Svitek; Michael A Mathier; Linda Cadaret; Guy A MacGowan; Dennis M McNamara; Srinivas Murali

Book ID: 119549737
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 241 KB
Volume: 43
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(04)92123-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term Follow-up After Conversion fro

Long-term Follow-up After Conversion from Intravenous Epoprostenol to Oral Therapy With Bosentan or Sildenafil in 13 Patients With Pulmonary Arterial Hypertension

✍ Roger F. Johnson; James E. Loyd; Amy L. Mullican; Cynthia A. Fink; Ivan M. Robbi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Effect of bosentan on exercise capacity

Effect of bosentan on exercise capacity in patients with pulmonary arterial hypertension or inoperable chronic thromboembolic pulmonary hypertension

✍ Hirashiki, Akihiro; Kondo, Takahisa; Nakano, Yoshihisa; Adachi, Shiro; Shimazu, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Effect of Bosentan on Exercise Capacity

Effect of Bosentan on Exercise Capacity in Patients with Pulmonary Arterial Hypertension or Inoperable Chronic Thromboembolic Pulmonary Hypertension

✍ Hirashiki, Akihiro; Kondo, Takahisa; Nakano, Yoshihisa; Adachi, Shiro; Okumura, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Long-term outcome and effects of oral bo

Long-term outcome and effects of oral bosentan therapy in Taiwanese patients with advanced idiopathic pulmonary arterial hypertension

✍ Hsao-Hsun Hsu; Jin-Shing Chen; Robert J. Chen; Wen-Je Ko; Shuenn-Wen Kuo; En-Tin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 221 KB

The effect of open label UT15 or bosenta

The effect of open label UT15 or bosentan on hospitalisation days in patients with pulmonary arterial hypertension (PAH)

✍ A.M Keogh; K.M Brown; C.A Corrigan; C Allada; Y Ten 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 77 KB

55: Incidence of abnormal liver function

55: Incidence of abnormal liver function tests in patients with Pulmonary Arterial Hypertension (PAH) treated for one year with sitaxsentan or bosentan

✍ R.E. Girgis; A.M. Keogh; R.L. Benza; R. Naeije 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 107 KB